LMRI — Lumexa Imaging Holdings Cashflow Statement
0.000.00%
- $898.63m
- $1.72bn
- $1.02bn
Annual cashflow statement for Lumexa Imaging Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -122 | -94.1 | -47.1 |
| Depreciation | |||
| Deferred Taxes | |||
| Non-Cash Items | 107 | 85.5 | 60.1 |
| Unusual Items | |||
| Equity in Net Earnings/Losses | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -4.14 | -2.6 | -44.3 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | 37.5 | 40.7 | 17.1 |
| Capital Expenditures | -24 | -27.8 | -23.5 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -5.65 | 5.49 | 2.52 |
| Acquisition of Business | |||
| Sale of Business | |||
| Sale of Fixed Assets | |||
| Change in Net Investments | |||
| Cash from Investing Activities | -29.7 | -22.3 | -21 |
| Financing Cash Flow Items | 2.25 | 0.167 | -14.6 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -8.77 | -12.5 | 36.6 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -0.912 | 5.95 | 32.7 |